18.07
Precedente Chiudi:
$18.17
Aprire:
$18.23
Volume 24 ore:
80,425
Relative Volume:
0.17
Capitalizzazione di mercato:
$1.04B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-10.32%
1M Prestazione:
-28.42%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Omada Health Inc Stock (OMDA) Company Profile
Nome
Omada Health Inc
Settore
Industria
Telefono
888-987-8337
Indirizzo
611 GATEWAY BLVD., SOUTH SAN FRANCISCO
Confronta OMDA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
OMDA
Omada Health Inc
|
18.04 | 1.05B | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
242.33 | 44.34B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
66.10 | 11.69B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
100.88 | 8.68B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.40 | 6.66B | 906.14M | -52.62M | 89.62M | -0.3621 |
|
DOCS
Doximity Inc
|
49.29 | 8.74B | 550.17M | 201.35M | 232.07M | 1.00 |
Omada Health Inc Stock (OMDA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-13 | Iniziato | BMO Capital Markets | Outperform |
| 2025-09-05 | Iniziato | Robert W. Baird | Neutral |
| 2025-07-01 | Iniziato | Barclays | Overweight |
| 2025-07-01 | Iniziato | Canaccord Genuity | Buy |
| 2025-07-01 | Iniziato | Evercore ISI | Outperform |
| 2025-07-01 | Iniziato | Goldman | Buy |
| 2025-07-01 | Iniziato | JP Morgan | Overweight |
| 2025-07-01 | Iniziato | Morgan Stanley | Overweight |
| 2025-07-01 | Iniziato | Needham | Buy |
Mostra tutto
Omada Health Inc Borsa (OMDA) Ultime notizie
Omada Health to Participate in Evercore Healthcare Conference - The Manila Times
United States 7MM Digital Therapeutics for Diabetes Market: FDA - openPR.com
Omada Health’s Strategic Growth and Profitability: A Buy Rating by Craig Hettenbach - TipRanks
OMDA: BMO Capital Initiates Coverage with "Outperform" Rating | - GuruFocus
Thought bubble: Omada's about-face - Axios
Omada Health initiated with an Outperform at BMO Capital - TipRanks
Omada Health Positioned for Growth with Strong Financial Performance and Strategic Market Opportunities - TipRanks
EBIT per share of Omada Health, Inc. – MUN:U76 - TradingView
Inside Omada's pivot toward GLP-1 prescriptions - Axios
Cash from financing activities of Omada Health, Inc. – FWB:U76 - TradingView
Omada Health Reports Strong Q3 2025 Growth - MSN
How Trump’s GLP-1 move may affect telehealth companies’ fortunes - Modern Healthcare News
Free cash flow per share of Omada Health, Inc. – MUN:U76 - TradingView
Omada Health, Inc. Earnings and Revenue – MUN:U76 - TradingView
Omada Health (OMDA): Assessing Valuation After Recent Stock Declines - Yahoo Finance
Latin America Digital Therapeutics Market Poised - openPR.com
Omada Health Stock Jumps Into Retail Focus As Wall Street Lifts Price Targets After ‘Beat And Raise’ Quarter, GLP-1 Push - Stocktwits
Omada Health, Inc. Balance Sheet – FWB:U76 - TradingView
Omada Health raises FY25 revenue view to $251.5M-$254.5M from $235M-$241M - MSN
Omada Health reports Q3 EPS (6c), consensus (7c) - MSN
Omada Health Reports Strong Growth and Innovation - MSN
Omada Health price target raised to $32 from $30 at Morgan Stanley - MSN
Omada Health price target raised to $28 from $27 at Evercore ISI - MSN
Evercore ISI Group Maintains Omada Health (OMDA) Outperform Recommendation - MSN
Why Omada Health is finally prescribing Ozempic as TrumpRx slashes GLP-1 weight-loss drug costs - Business Insider
Omada Health Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Omada Health to prescribe GLP-1s - TechTarget
Evercore ISI Group Raises Price Target for OMDA to $28.00 | OMDA Stock News - GuruFocus
Omada Health, Inc.: Strong Revenue Momentum and Strategic Partnerships Drive Buy Rating - TipRanks
Omada Health to present RWE on behavior change program at ObesityWeek - MSN
Omada Health, Inc.: Strong Market Position and Growth Potential Drive Buy Rating - TipRanks
Omada Health Inc (OMDA) Q3 2025 Earnings Call Highlights: Record Membership Growth and ... By GuruFocus - Investing.com Canada
Omada Health Q3 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Omada Health Q3 2025 sees revenue growth, stock dips - Investing.com India
Omada Health announces GLP-1 prescribing capability - TipRanks
Compared to Estimates, Omada Health, Inc. (OMDA) Q3 Earnings: A Look at Key Metrics - Yahoo Finance
Omada Health announces GLP-1 prescribing capability to support growing member population - MarketScreener
Earnings Flash (OMDA) Omada Health, Inc. Reports Q3 Revenue $68.0M, vs. FactSet Est of $61.3M - MarketScreener
Omada Health, Inc. (OMDA) Q3 FY2025 earnings call transcript - Yahoo Finance
Omada Health Reports Third Quarter 2025 Results - The Manila Times
Omada Health Announces GLP-1 Prescribing Capability to Support Growing Member Population - The Manila Times
Omada Health (NASDAQ: OMDA) to offer GLP-1 prescribing nationwide; members up 53% YoY - Stock Titan
[8-K] Omada Health, Inc. Reports Material Event | OMDA SEC FilingForm 8-K - Stock Titan
Startup Omada Health to start prescribing GLP-1s, other obesity medications as membership grows - CNBC
Earnings To Watch: Omada Health Inc (OMDA) Reports Q3 2025 Resul - GuruFocus
Earnings To Watch: Omada Health Inc (OMDA) Reports Q3 2025 Result - Yahoo Finance
Revenue per share of Omada Health, Inc. – NASDAQ:OMDA - TradingView
EBITDA per share of Omada Health, Inc. – SWB:U76 - TradingView
ETFs Investing in Omada Health, Inc. Stocks - TradingView
Omada Health (Nasdaq: OMDA) shows 0.8% after GLP-1 discontinuation, 63.2% maintained/lost - Stock Titan
Omada Health, Inc.: Strategic Growth and Market Penetration Drive Buy Rating - TipRanks
Omada Health Inc Azioni (OMDA) Dati Finanziari
Non sono disponibili dati finanziari per Omada Health Inc (OMDA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):